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Abstract
Background: Intracavernous injection of cultured adipose-derived stem cells (ADSCs)
effectively restores erectile function in cavernous nerve (CN)–injured rats when admin-
istered at the time of injury. However, culturing exposes ADSCs to the risk of contami-
nation and dedifferentiation.
Objective: Explore the effect of uncultured autologous adipose-derived stromal vascular
fraction (SVF) on improving erectile function in a rat model of CN injury when
administered at the time of injury or 4 wk after injury.
Design, setting, and participants: Eighty-ninemale Sprague Dawley rats were randomly
divided into four groups. CN injury or sham surgery was performed at the start of the
study, and rats were treated with either SVF or vehicle. Functional testing and histologic
analysis were performed 12 wk after CN crush or sham surgery.
Intervention: We used intracavernous injection of saline immediately after CN crush
(n = 23), intracavernous injection of SVF immediately after CN crush (n = 17), intraca-
vernous injection of SVF 4 wk after CN crush (n = 23), or sham surgery (n = 26).
Outcome measurements and statistical analysis: We studied intracavernous pressure
(ICP) response to CN electrostimulation and performed histologic examination of
midpenile cross-sections. Data were analyzed using one-way analysis of variance
followed by the Tukey-Kramer test.
Results and limitations: Both immediate and delayed treatment with SVF resulted in a
significantly increased ICP-to-mean arterial pressure ratio compared with the vehicle-
treated group. Both immediate and delayed treatment with SVF significantly increased
expression of neuronal nitric oxide synthase and neurofilament in dorsal penile nerves
compared to the vehicle group. Furthermore, the smooth muscle-to-collagen ratio
within the corpus cavernosum was significantly improved in both of the SVF groups
compared to vehicle-treated rats. The main limitation of the study is the lack of
determination of the SVF components.
ured autologous SVF injected immediately or 4 wk after CN crush
nction, promoted nerve regeneration, and prevented fibrosis of theConclusions: Uncult
improved erectile fu
corpus cavernosum following CN injury.
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Radical prostatectomy (RP) is considered the gold standard
for the treatment of clinically localized prostate cancer,
with excellent long-term oncologic results [1]. Despite
the advantagesofnerve-sparing techniquesand laparoscopic
androbot-assistedsurgery, erectiledysfunction (ED) remains
a frequent complicationof RP [2,3]. Phosphodiesterase type5
inhibitors are commonly used to treat ED after RP, but their
efficacy has beendisappointing formanyEDpatients after RP
[4,5]. Therefore, there is an urgent need to develop novel and
effective strategies for the treatment of ED after RP.
Adipose tissue has been suggested as an attractive and
abundant stem cell source [6]. Similar to bone marrow
mesenchymal stemcells, adipose-derived stem cells (ADSCs)
are multipotent, self-renewing cells with the potential to
differentiate into several cell types [7–9]. In addition, it has
been demonstrated that ADSCs are capable of secreting
multiple growth factors and cytokines [10]. Intracavernous
injection of cultured ADSCs has been shown to improve
erectile function and result in preservation of the corpus
cavernosum microstructure in rat models of ED associated
with hyperlipidemia [11], diabetes mellitus [12], and
cavernous nerve (CN) injury [13].
Most types of adult stem cells require isolation and
expansion in vitro to obtain cell numbers adequate for
achieving beneficial effects [14]. ADSCs are isolated from the
stromal vascular fraction (SVF) of adipose tissue and culture-
expanded in various conditions [15]. The risks of xenogenic
nutritional sources, microbial contamination, and tumori-
genesis during cell culture raise concerns regarding implan-
tation of these cultured stem cells into human subjects [16].
To avoid these risks, SVF isolation and administration
without culturing has been proposed as an easier and safer
way to use stem and progenitor cells in adipose tissue for
treatment. Human clinical trials have recently been initiated
thatuse injectionof SVFduringbreast reconstruction surgery
and to treat myocardial infarction, traumatic calvarial
defects, lipodystrophy, and type 1 and 2 diabetes [17].
Another caveat of previous studies using ADSCs for the
treatment of ED was administration at the time of CN injury.
However, to serve as a treatment for nerve regeneration in
humans, itwouldbemoredesirable toadminister theagentat
a later time point after injury, when it becomes clearerwhich
patient population would benefit most from treatment
(ie, those developing ED after nerve-sparing prostatectomy).
We hypothesized that SVF is effective in improving erectile
function following CN injury. The aim of this study was to
examine the therapeutic effects of immediate and delayed
treatment with intracavernous injection of uncultured auto-
logous adipose-derived SVF on erectile function and corpus
cavernosum microstructure in a rat model of CN injury.
2. Materials and methods
2.1. Study design
Eighty-nine Sprague Dawley rats (12wk old)were obtained fromCharles
River Laboratories (Wilmington, MA, USA). Sixty-three rats underwentbilateral CN crush injury and were randomly divided into three groups:
intracavernous injection of saline (vehicle; n = 23), intracavernous
injection of SVF immediately after CN crush (immediate treatment;
n = 17), and intracavernous injection of SVF 4wk after CN crush (delayed
treatment; n = 23). The remaining rats underwent sham surgery (sham;
n = 26). Twelveweeks after CN crush or sham surgery, all rats underwent
erectile function measurement. Thereafter, they were sacrificed, and
penile tissue was harvested for histologic analysis. All procedures were
approved by the Institutional Animal Care and Use Committee at the
University of California, San Francisco. All functional tests and histologic
assessments were performed in a strictly blinded fashion.
2.2. Cavernous nerve injury
Under isofluraneanesthesia, themajorpelvic ganglion (MPG)andCNwere
exposed on both sides of the prostate via amidline laparotomy. No further
manipulation occurred in the sham group, while bilateral CN crush injury
was performed as described previously in all other groups [13].
2.3. Isolation of stromal vascular fraction
During the same surgery or 4 wk after CN injury, perigonadal adipose
tissue was harvested in all rats. Adipose tissue was washed with
sterile saline and minced, followed by enzymatic digestion with Adipase
(TissueGenesis,Honolulu,HI,USA) at 37 8C for 30 min. The cellswere then
washed and centrifuged, and the pellet was resuspended in saline. The
nucleated cells from the pellet were counted with an automated cell
counter and diluted to 5000 cells per microliter in saline.
2.4. Intracavernous injection of stromal vascular fraction
Under isoflurane anesthesia, a skin incision was made to expose the
penis, and either 400 ml SVF solution (5000 cells per microliter) or 400 ml
saline was injected into the corpus cavernosum with a 25-gauge needle.
An elastic band was placed at the base of the penis immediately before
injection and was removed 3 min after injection.
2.5. Erectile function evaluation
Intracavernouspressure (ICP) response toelectrostimulationof theCNwas
usedtoevaluateerectile function[18].Briefly,underketamine (100mg/kg)
and midazolam (5mg/kg) anesthesia, the CNs were exposed via midline
laparotomy. The corpus cavernosum was cannulated with a heparinized
(200 U/ml) 25-gauge needle connected to a pressure transducer
(Utah Medical Products, Midvale, UT, USA). The stimulus parameters were
1.5mA, 20 Hz, pulse width of 0.2ms, and duration of 50 s. The maximum
increase of ICP of three stimuli per side was selected for statistical analysis
in each animal. Mean arterial blood pressure (MAP) was recorded using a
25-gauge needle inserted into the aortic bifurcation [13,18].
2.6. Histology
The penile midshaft was harvested and fixed with 2% formaldehyde and
0.002% picric acid in 0.1-M phosphate buffer saline (PBS) for 4 h,
followed by immersion in 30% sucrose in PBS overnight at 4 8C. Tissues
were embedded into optimal cutting temperature compound (Sakura
Finetek, Torrance, CA, USA). Sections were cut at a thickness of 5 mm.
Immunohistochemical staining was performed according to a
previously described protocol [18]. The primary antibodies included
rabbit antineuronal nitric oxide synthase (nNOS; 1:100; Santa Cruz
Biotechnologies, Santa Cruz, CA, USA) andmouse antineurofilament (NF;
1:500; this antibody was obtained from the developmental Studies
Hybridoma Bank, developed under the auspices of the National Institute
of Child Health and Human Development and maintained by the
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Fig. 1 – Electrostimulation of cavernous nerves (CN) at 12 wk. (a) Representative intracavernous pressure (ICP) recording of each experimental group. The
black curve represents ICP values in response to CN stimulation. The red bar represents 50-s electrical stimulation of the CN. (b) The effect of stromal
vascular fraction treatment in improving the ICP-to- mean arterial pressure ratio.
ICP = intracavernous pressure; MAP =mean arterial pressure.
* p < 0.05 compared with vehicle group.
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stained by incubation with Alexa-488–conjugated phalloidin (1:400;
Invitrogen, Carlsbad, CA, USA) for 20 min at room temperature. The
secondary antibodies used included Alexa-488– and Alexa-594–
conjugated antibodies (1:500; Invitrogen). Nuclei were stained with
4’,6-diamidino-2-phenylindole (DAPI; Invitrogen).
Masson’s trichrome staining procedures were performed according
to a previously described protocol [19]. Image analysis was performed by
computerized densitometry using Image-Pro Plus 5.1 (Media Cybernet-
ics, Silver Spring, MD, USA). To quantify smooth muscle, the percentage
of f-actin bright positive area within the corpus cavernosum was
analyzed. Masson’s trichrome staining was used to quantify the ratio
between smoothmuscle and collagenwithin the corpus cavernosum. For
nNOS and NF staining, the ratio between nNOS or NF positive area and
total dorsal nerve area was calculated.
2.7. Statistical analysis
The results were analyzed using GraphPad Prism v.4 software (GraphPad
Software, La Jolla, CA, USA) and expressed as mean plus or minus
standard deviation. Multiple groups were compared using one-way
analysis of variance followed by the Tukey-Kramer test for post hoc
comparisons. Statistical significance was set at p < 0.05.Table 1 – Neuronal nitric oxide synthase, neurofilament, actin, and M
Group nNOS content
in dorsal nerve, %
NF content in
dorsal nerve, %
Sham 1.46  0.39** 14.64  2.36**
Vehicle 0.77  0.24 8.4  2.08
Immediate 1.19  0.25** 12.62  2.62**
Delayed 1.08  0.25** 13.12  2.21**
nNOS = neuronal nitric oxide synthase; NF = neurofilament; SM = smooth muscle
* Histomorphometric digital analysis was performed on each tissue section of the
positive area in the dorsal nerve area. SM was expressed as a percentage of the a
collagen within the corpus cavernosum was analyzed for Masson’s trichrome sta
* p < 0.05 compared with vehicle group.3. Results
3.1. Stromal vascular fraction treatment improves erectile
function after cavernous nerve injury
CN injury consistently resulted in decreased erectile
function compared to sham animals (Fig. 1). Recovery of
erectile functionwas observed in both SVF-treated groups, as
reflected by a significantly increased ICP/MAP response
to CN electrostimulation compared to the vehicle group.
There was no significant difference between the immediate-
treatment group and the delayed-treatment group.
3.2. Histologic data
3.2.1. Stromal vascular fraction treatment promotes nerve
regeneration
Examination of nNOS and NF contents revealed nerve injury
in the vehicle group, as illustrated by a significant decrease of
positive immunostaining compared to the sham group
(Figs. 2 and3; Table1). Following SVF treatment immediatelyasson’s trichrome staining data in each experimental group*
SM content in
corpus cavernosum, %
Ratio between SM and
collagen in corpus cavernosum
5.67  1.05** 0.089  0.0224**
3.57  0.69 0.0445  0.0182
4.72  0.061** 0.0714  0.0098**
4.51  0.67** 0.0701  0.0166**
.
rat penis. nNOS and NF were expressed as a percentage of the nNOS- or NF-
ctin-positive area within the corpus cavernosum. The ratio between SM and
ining.
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Fig. 2 – Neuronal nitric oxide synthase (nNOS) staining in a penile midshaft specimen. Representative images of nNOS-positive fibers in penile dorsal nerve
of each experimental group are presented. NNOS-positive fibers were stained red (arrow) in the dorsal nerve. Original magnification is T400.
nNOS = neuronal nitric oxide synthase; DAPI = 4’,6-diamidino-2-phenylindole.
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as well as the total axonal content (NFs) were significantly
higher in both groups compared to the vehicle group. There
was no significant difference between the immediate and
delayed treatments.
3.2.2. Stromal vascular fraction treatment improves cavernosal
smooth muscle content
Asignificantlydecreasedsmoothmuscle content and smooth
muscle-to-collagen ratio within the corpus cavernosum in
the vehicle group compared to the sham group revealed the
development of corpus cavernosum fibrosis following CN
injury (Fig. 4; Table 1). Both SVF treatments partially but
significantly restored the smooth muscle content and
reduced fibrosis. Again, no significant difference was noted
when SVF was administered immediately versus delayed.
4. Discussion
Cell culture expansion of stem cells is often required to reach
sufficient cell numbers for therapeutic purposes. However,
currentmajor restrictions regarding the use of cultured cellsin human subjects include contamination, unexpected cell
differentiation, and tumorigenesis [20]. Unlike other stem
cells that are present in low concentrations in their native
tissues, ADSCs have been shown to be abundantly present in
adipose tissue [21]. Most importantly, compared to other
stem cell sources such as bone marrow, large amounts of
adipose tissue can be harvested with minimal or no side
effects fromhuman subjects, providing a new perspective on
using adipose tissue–derived cells in the clinical setting.
Adipose tissue is composed of two main cell populations:
mature adipocytes and the SVF. SVF is a heterogeneous
fraction containing preadipocytes, mature endothelial cells,
vascular smooth muscle cells, macrophages, fibroblasts, and
a large population of stem/progenitor cells [15,22].
In the present study, SVF was isolated from adipose
tissue and injected intracavernously into rats after CN
injury. Compared to previous studies in this setting, there
was notable spontaneous nerve regeneration in untreated
animals [18,23], likely the result of the long time interval
between nerve injury and evaluation. However, this nerve
regeneration was significantly improved by SVF injection. It
can be speculated that the stem/progenitor cells in the SVF
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Fig. 3 – Neurofilament (NF) staining in a penile midshaft specimen. Representative images are presented for NF-positive fibers in penile dorsal nerve of
each experimental group. Original magnification is T400.
NF = neurofilament; DAPI = 4’,6-diamidino-2-phenylindole.
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function of CN-injured rats by producing pro-survival,
antiapoptotic, and neurotrophic factors [24,25]. We have
confirmed these neuroregenerative processes of ADSC in
previous studies in which early migration of ADSC toward
the MPG was observed [19].
This is the first study to examine the effects of stem cell
treatment for ED in a chronic state after nerve trauma.
Functional recovery and penile histologic improvement
were observed when treatment was delayed by 4 wk, when
neurodegeneration and end-organ damage, including fibro-
sis, have occurred. The effects of the delayed administration
of SVF are in agreement with results from stem cell studies
in the central nervous system. Direct injection of bone
marrow stromal cells in the brain 2mo after traumatic brain
injury have resulted in neuroregeneration [26]. In addition,
systemic injection of umbilical tissue–derived cells in a
similar brain injury model resulted in locally increased
vascular density and decreased apoptosis, thus supporting
functional recovery [27]. In the present study, we found
decreased fibrosis in the corpus cavernosum. Whether thiseffect is secondary to reinnervation and reoxygenation of
the corpus cavernosum or the result of local interaction
between stem cells and the extracellular matrix remains
undetermined. It has previously been shown that ADSCs
produce matrix-metalloproteinases that may aid in reduc-
ing deposited collagen following corpus cavernosum
denervation [28]. That said, it has also been shown that
ADSCs migrate away from the corpus cavernosum early
after injection [19].
We believe that this study bridges an important gap in
translating the results of previous ADSC studies toward the
clinical setting and application in human subjects. In the
current age, SVF is being used in various clinical trials and
has been proven safe and effective in various settings [17].
With the observation of the beneficial effects of SVF
replicating those of ADSCs, a novel approach that is directly
applicable in the clinical setting has been identified, and
initial clinical studies can now be expected within a short
time frame. Liposuction and injection of SVF during the
same procedure as RPmay be a reasonable treatment option
for preoperatively motivated patients. Furthermore, the
[(Fig._4)TD$FIG]
Fig. 4 – Masson’s trichrome and phalloidin staining in a penile midshaft specimen. (a) Representative images of actin staining of each experimental group.
Smooth muscle in corpus cavernosum was stained red. Original magnification is T40. (b) Representative images of Masson’s trichrome staining of each
experimental group. Smooth muscle and connective tissue are stained red and green, respectively. Original magnification is T40.
DAPI = 4’,6-diamidino-2-phenylindole.
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can also be given several weeks following prostatectomy at
the time patients begin attempting sexual intercourse.
There are some important limitations to this study. First,
ICP/MAP values exceeding 1 were noted in few rats, which
may appear supraphysiologic. However, ICP can be raised to
several hundred mmHg if both the cavernous and pudendal
nerves are stimulated [29]. This outcome may happen
during stimulation when the current spreads to the
pudendal efferent nerve fibers because of the scars around
the MPG and CNs. The prolonged observation time after
injury may have allowed for more extensive scar develop-
ment. Second, the exact composition of the rat SVF was
not examined in this study. However, it is likely that the
cell elements in the SVF of the rat are comparable to
those in human SVF [30]. Third, we have not determined
whether the decreased fibrosis in the corpus cavernosum
is the result of a direct interaction between ADSC and
the extracellular matrix or whether this is the result of
increased innervation of the corpus cavernosum. Further
research is ongoing to determine these interactions and to
further understand the effects of cellular therapies in ED
following CN injury.
5. Conclusions
Autologous SVF injected immediately or 4wk after CN crush
improved erectile function, promoted nerve regeneration,
and prevented fibrosis of the corpus cavernosum following
CN injury. The clinical availability of routine SVF isolation
devicesmerits the study of autologous SVF therapy in penile
rehabilitation following RP in the near future.
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